Adverse drug reactions of imatinib in patients with chronic myeloid leukemia: A single-center surveillance study
Objective: To monitor the adverse drug reactions (ADRs) associated with imatinib treatment
in patients with chronic myeloid leukemia (CML) in a tertiary care hospital. Materials and …
in patients with chronic myeloid leukemia (CML) in a tertiary care hospital. Materials and …
Analysis of adverse drug reactions of imatinib in chronic myeloid leukemia patients: An Eastern Indian experience
TR Swain, S Goutam, RK Jena… - Indian Journal of …, 2022 - journals.lww.com
BACKGROUND: Imatinib mesylate is the cornerstone therapy in the management of chronic
myeloid leukemia (CML). Monitoring of adverse drug reactions (ADRs) of imatinib in our …
myeloid leukemia (CML). Monitoring of adverse drug reactions (ADRs) of imatinib in our …